Pfizer has reported its quarterly profit, exceeding Wall Street estimates. The company's strong performance is attributed to high demand for a specific product. The pharmaceutical company has also adjusted its full-year revenue forecast, raising the lower end of the expected range.

This change comes after the company's second-quarter profit beat estimates. Further details on Pfizer's quarterly performance and revised forecast can be found through Reuters, as reported in the Galveston County Daily News.